Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion
Impacto
![Google Scholar](/xmlui/themes/Mirage2/images/uji/logo_google.png)
![Microsoft Academico](/xmlui/themes/Mirage2/images/uji/logo_microsoft.png)
Metadatos
Mostrar el registro completo del ítemcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONEste recurso está restringido
https://doi.org/10.1007/s40618-022-01739-0 |
Metadatos
Título
Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussionAutoría
Fecha de publicación
2022-01-11Editor
SpringerISSN
0391-4097; 1720-8386Cita bibliográfica
Pla Peris, B., Merchante Alfaro, A.Á., Maravall Royo, F.J. et al. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion. J Endocrinol Invest 45, 1071–1077 (2022). https://doi.org/10.1007/s40618-022-01739-0Tipo de documento
info:eu-repo/semantics/articleVersión
info:eu-repo/semantics/publishedVersionPalabras clave / Materias
Resumen
Aim To describe a case series of thyrotoxicosis likely triggered by SARS-CoV-2 vaccination and to warn physicians about
this potential correlation. To report clinical, laboratory and imaging fndings and provide further ... [+]
Aim To describe a case series of thyrotoxicosis likely triggered by SARS-CoV-2 vaccination and to warn physicians about
this potential correlation. To report clinical, laboratory and imaging fndings and provide further information that goes in
line with the underlying mechanisms.
Methods Single-center case series based on all the information collected in the hospital medical records, as well as the
temporal sequence between the onset of symptoms and COVID-19 vaccination.
Results We report 8 cases with thyrotoxicosis after SARS-CoV-2 vaccination. 4 cases of Graves’ disease (GD), 2 cases of
subacute painful thyroiditis (SAT), 1 case of concurrent GD and SAT and 1 case of atypical subacute thyroiditis. Five patients
received BNT162b2 mRNA vaccine, 3 patients 1273 mRNA vaccine. The onset of symptoms following vaccination ranged
from 10 to 14 days in six of eight patients and from 7 to 8 weeks in two patients.
Conclusions Several hypotheses have been proposed to explain the potential correlation between SARS-CoV-2 vaccination
and thyrotoxicosis, including immune system hyper-stimulation, molecular mimicry and Autoimmune/Autoinfammatory
Syndrome Induced by Adjuvants (ASIA). We should pay greater attention to thyroid disorders in patients receiving vaccine
against SARS-CoV-2. [-]
Publicado en
Journal of Endocrinological Investigation, volume 45, pages1071–1077 (2022)Derechos de acceso
Copyright © 2022, Italian Society of Endocrinology (SIE)
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
Aparece en las colecciones
- MED_Articles [657]